Coumarin-chalcone hybrids as inhibitors of MAO-B: Biological activity and in silico studies
dc.contributor.author | Moya-Alvarado, Guillermo | |
dc.contributor.author | Yañez, Osvaldo | |
dc.contributor.author | Morales, Nicole | |
dc.contributor.author | González-González, Angélica | |
dc.contributor.author | Areche, Carlos | |
dc.contributor.author | Núñez, Marco Tulio | |
dc.contributor.author | Fierro, Angélica | |
dc.contributor.author | García-Beltrán, Olimpo | |
dc.date.accessioned | 2023-03-31T14:17:10Z | |
dc.date.available | 2023-03-31T14:17:10Z | |
dc.date.issued | 2021-04 | |
dc.description | Indexación: Scopus | es |
dc.description.abstract | Fourteen coumarin-derived compounds modified at the C3 carbon of coumarin with an α,β-unsaturated ketone were synthesized. These compounds may be designated as chalcocoumarins (3-cinnamoyl-2H-chromen-2-ones). Both chalcones and coumarins are recognized scaffolds in medicinal chemistry, showing diverse biological and pharmacological properties among which neuro-protective activities and multiple enzyme inhibition, including mitochondrial enzyme systems, stand out. The evaluation of monoamine oxidase B (MAO-B) inhibitors has aroused considerable interest as therapeutic agents for neurodegenerative diseases such as Parkinson’s. Of the fourteen chalcocumarins evaluated here against MAO-B, ChC4 showed the strongest activity in vitro, with IC50 = 0.76 ± 0.08 µM. Computational docking, molecular dynamics and MM/GBSA studies, confirm that ChC4 binds very stably to the active rMAO-B site, explaining the experimental inhibition data. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. | es |
dc.description.uri | https://www.mdpi.com/1420-3049/26/9/2430 | |
dc.identifier.citation | Molecules Volume 26, Issue 922 April 2021 Article number 2430 | es |
dc.identifier.doi | 10.3390/molecules26092430 | |
dc.identifier.issn | 1420-3049 | |
dc.identifier.uri | https://repositorio.unab.cl/xmlui/handle/ria/48090 | |
dc.language.iso | en | es |
dc.publisher | MDPI | es |
dc.rights.license | Atribución 4.0 Internacional (CC BY 4.0) | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/deed.es | |
dc.subject | Chalcocoumarin | es |
dc.subject | In silico studies | es |
dc.subject | MAO-B | es |
dc.subject | Molecular dynamics | es |
dc.subject | Neurodegenerative diseases | es |
dc.title | Coumarin-chalcone hybrids as inhibitors of MAO-B: Biological activity and in silico studies | es |
dc.type | Artículo | es |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- Moya_G_Coumarin_Chalcone_Hybrids_as_Inhibitors_2021_Article.pdf
- Tamaño:
- 3.1 MB
- Formato:
- Adobe Portable Document Format
- Descripción:
- TEXTO COMPLETO EN INGLES
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: